SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0000947871-23-000305
Filing Date
2023-03-09
Accepted
2023-03-09 08:07:34
Documents
3
Group Members
FENNEC ACQUISITION INCSINO BIOPHARMACEUTICAL LTD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 19 ss1849734_sctota.htm SC TO-T/A 48159
2 PRESS RELEASE ss1849734_ex99a5e.htm EX-99.A5(E) 17308
3 GRAPHIC image_001.jpg GRAPHIC 10086
  Complete submission text file 0000947871-23-000305.txt   81243
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-89626 | Film No.: 23718245
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 PRINCETON MEWS 167-169 LONDON ROAD KINGSTON UPON THAMES SURREY X0 KT2 6PT
Business Address 1 PRINCETON MEWS 167-169 LONDON ROAD KINGSTON UPON THAMES SURREY X0 KT2 6PT 44-7541691673
Invox Pharma Ltd (Filed by) CIK: 0001932556 (see all company filings)

IRS No.: 000000000
Type: SC TO-T/A